Similar articles

• Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.

  Babu S. Babu S. Natl Med J India. 2003 May-Jun;16(3):175; author reply 175-6. Natl Med J India. 2003. PMID: 12929872 No abstract available.
• Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.

  Desai HG. Desai HG. Natl Med J India. 2003 May-Jun;16(3):175; author reply 175-6. Natl Med J India. 2003. PMID: 12929870 No abstract available.
• Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.

  Aggarwal R, Ghoshal UC, Naik SR. Aggarwal R, et al. Natl Med J India. 2002 Nov-Dec;15(6):320-7. Natl Med J India. 2002. PMID: 12540064
• [Medico-economic assessment of the therapeutic management of patients with hepatitis C].

  Loubière S, Rotily M, Moatti JP. Loubière S, et al. Gastroenterol Clin Biol. 2000 Nov;24(11):1047-51. Gastroenterol Clin Biol. 2000. PMID: 11139674 Review. French.
• Economics of chronic hepatitis B and hepatitis C.

  Rajendra A, Wong JB. Rajendra A, et al. J Hepatol. 2007 Oct;47(4):608-17. doi: 10.1016/j.jhep.2007.07.016. Epub 2007 Jul 30. J Hepatol. 2007. PMID: 17697724 Review.